ISMAEL GALVE ROPERH-rekin lankidetzan egindako argitalpenak (21)

2022

  1. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

2021

  1. Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain

    British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192

  2. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2015

  1. CB1 Cannabinoid receptor-dependent activation of mTORC1/Pax6 signaling drives Tbr2 expression and basal progenitor expansion in the developing mouse cortex

    Cerebral Cortex, Vol. 25, Núm. 9, pp. 2395-2408

2012

  1. The CB1 cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis

    Journal of Neuroscience, Vol. 32, Núm. 47, pp. 16651-16665

2011

  1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136

2009

  1. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

    Brain, Vol. 132, Núm. 11, pp. 3152-3164

  2. The endocannabinoid system and the regulation of neural development: Potential implications in psychiatric disorders

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Núm. 7, pp. 371-382

2008

  1. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 25, pp. 8760-8765

  2. Mechanisms of control of neuron survival by the endocannabinoid system

    Current Pharmaceutical Design, Vol. 14, Núm. 23, pp. 2279-2288

  3. Targeting cannabinoid receptors in brain tumors

    Cannabinoids and the Brain (Springer US), pp. 361-374

  4. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis (Journal of Biological Chemistry (2007) 282, (23892-23898))

    Journal of Biological Chemistry

  5. The CB2 cannabinoid receptor controls myeloid progenitor trafficking: Involvement in the pathogenesis of an animal model of multiple sclerosis

    Journal of Biological Chemistry, Vol. 283, Núm. 19, pp. 13320-13324

2007

  1. Cannabinoids and gliomas

    Molecular Neurobiology, Vol. 36, Núm. 1, pp. 60-67

  2. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis

    Journal of Biological Chemistry, Vol. 282, Núm. 9, pp. 6854-6862

  3. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis

    Journal of Biological Chemistry, Vol. 282, Núm. 33, pp. 23892-23898

  4. The endocannabinoid system and neurogenesis in health and disease

    Neuroscientist, Vol. 13, Núm. 2, pp. 109-114

2006

  1. Endocannabinoids: A new family of lipid mediators involved in the regulation of neural cell development

    Current Pharmaceutical Design, Vol. 12, Núm. 18, pp. 2319-2325

  2. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

    FASEB Journal, Vol. 20, Núm. 13

  3. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells

    Journal of Neuroscience, Vol. 26, Núm. 5, pp. 1551-1561